These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9380727)

  • 21. Antigen-driven bystander suppression after oral administration of antigens.
    Miller A; Lider O; Weiner HL
    J Exp Med; 1991 Oct; 174(4):791-8. PubMed ID: 1717632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.
    Hilliard B; Ventura ES; Rostami A
    Mult Scler; 1999 Feb; 5(1):2-9. PubMed ID: 10096096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy.
    Jewell SD; Gienapp IE; Cox KL; Whitacre CC
    Immunol Cell Biol; 1998 Feb; 76(1):74-82. PubMed ID: 9553779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
    Santos LM; al-Sabbagh A; Londono A; Weiner HL
    Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression.
    Sun JB; Xiao BG; Lindblad M; Li BL; Link H; Czerkinsky C; Holmgren J
    Int Immunol; 2000 Oct; 12(10):1449-57. PubMed ID: 11007763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
    Farooq SM; Ashour HM
    Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term immunologic consequences of experimental stroke and mucosal tolerance.
    Gee JM; Zierath D; Hadwin J; Savos A; Kalil A; Thullbery M; Becker KJ
    Exp Transl Stroke Med; 2009 Oct; 1():3. PubMed ID: 20142990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
    Gregorian SK; Rostami A
    J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.
    Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL
    Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species.
    Miller A; Lider O; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1992 Aug; 39(3):243-50. PubMed ID: 1379607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
    Pope L; Paterson PY; Miller SD
    J Neuroimmunol; 1992 Apr; 37(3):177-89. PubMed ID: 1373153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
    Wang ZY; He B; Qiao J; Link H
    J Neuroimmunol; 1995 Dec; 63(1):79-86. PubMed ID: 8557828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cells maintain long-term tolerance to myelin basic protein by inducing a novel, dynamic state of T cell tolerance.
    Cabbage SE; Huseby ES; Sather BD; Brabb T; Liggitt D; Goverman J
    J Immunol; 2007 Jan; 178(2):887-96. PubMed ID: 17202350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anamnestic recall of stroke-related deficits: an animal model.
    Zierath D; Hadwin J; Savos A; Carter KT; Kunze A; Becker KJ
    Stroke; 2010 Nov; 41(11):2653-60. PubMed ID: 20947846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.
    Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL
    J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to experimental autoimmune encephalomyelitis induced by neonatal tolerization to myelin basic protein: clonal elimination vs. regulation of autoaggressive lymphocytes.
    Qin YF; Sun DM; Goto M; Meyermann R; Wekerle H
    Eur J Immunol; 1989 Feb; 19(2):373-80. PubMed ID: 2467819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral tolerance induction by myelin basic protein on Vbeta8+ Lewis rat T cells.
    Goldman-Brezinski S; Brezinski K; Zhang XM; Gienapp I; Cox K; Heber-Katz E; Whitacre C
    J Neurosci Res; 1998 Jan; 51(1):67-75. PubMed ID: 9452310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.
    Khoury SJ; Gallon L; Chen W; Betres K; Russell ME; Hancock WW; Carpenter CB; Sayegh MH; Weiner HL
    J Exp Med; 1995 Aug; 182(2):357-66. PubMed ID: 7543136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
    Frenkel D; Huang Z; Maron R; Koldzic DN; Hancock WW; Moskowitz MA; Weiner HL
    J Immunol; 2003 Dec; 171(12):6549-55. PubMed ID: 14662856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.